- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$725.86 MnMarket Estimate, 2026
$748.51 MnMarket Forecast, 2034
$957.06 MnCAGR, 2026–2034
3.12%Global Niacinamide Market Size, Growth, Trends & Forecast (2026–2034)
The global niacinamide market size was valued at USD 725.86 million in 2025, is anticipated to be worth USD 748.48 million in 2026, and is expected to reach USD 928.10 million by 2034, growing at a compound annual growth rate (CAGR) of 3.12% during the forecast period from 2026 to 2034. Growth is primarily propelled by expanding applications in cancer and chronic disease treatments, surging skincare and cosmetics demand, and widespread usage in animal nutrition.
Key Executive Metrics (At-a-Glance)
- 2025 Base Valuation: USD 725.86 million
- 2026 Current Valuation: USD 748.48 million
- 2034 Forecast Valuation: USD 928.10 million
- Compound Annual Growth Rate (CAGR): 3.12% (2026–2034)
- Dominant Grade Segment: Pharmaceutical-grade segment (accounted for the highest share in 2025)
- Dominant Form Segment: Granular segment (led the global market worldwide in 2025)
- Dominant End-User Segment: Human nutrition segment (anticipated to lead globally during the forecast period)
- Dominant Region: North America (dominated in 2025), with Asia-Pacific projected to hold the largest share during the forecast period
Core Market Drivers
- Therapeutic and Oncological Applications: Niacinamide's role in cancer treatments, skin cancer prevention, PARP-1 gene regulation, and chronic kidney disease phosphate management.
- Skincare and Cosmetics Expansion: Rising preference for niacinamide in anti-aging, acne treatment, oil control, and hair care formulations.
Primary Market Restraints & Challenges
- Lack of Awareness & Side Effects: Limited consumer knowledge in certain regions coupled with potential mild adverse reactions such as skin burning, itching, or gastrointestinal discomfort.
- Regulatory Hurdles: Strict statutory approval frameworks and compliance controls governing dietary supplements and pharmaceutical-grade ingredients.
Global Niacinamide Market Segmentation Breakdown
| Segment Category | Leading Sub-Segment | Other Sub-Segments |
|---|---|---|
| By Grade | Pharmaceutical Grade (Highest share in 2025) | Feed Grade |
| By Form | Granular (Led worldwide in 2025) | Powder, Liquid |
| By End-User | Human Nutrition (Anticipated to lead) | Pharmaceuticals, Cosmeceuticals, Animal Nutrition |
| By Region | North America (Dominant in 2025) / Asia-Pacific (Fastest growth) | Europe, Latin America, Middle East & Africa |
Major Industry Players Profiled
Key global market leaders include Merck KGaA, BASF SE, Lonza, Koninklijke DSM N.V., Bactolac Pharmaceuticals, Inc., Foodchem International Corporation, Evonik Industries AG, Jubilant Life Sciences Limited, Vertellus Specialties Inc., Vanetta, Fagron, Inc., ZHEJIANG NHU COMPANY LTD., Brother Enterprises Holding Co., Ltd., and Lasons India Pvt. Ltd.
Global Niacinamide Market Size
The global niacinamide market size was valued at USD 725.86 million in 2025. The market is forecasted to be worth USD 928.10 million by 2033 from USD 725.86 million in 2025, growing at a CAGR of 3.12% from 2026 to 2034.
Niacinamide is one of the forms of vitamin B3, and it is also known as nicotinamide. Niacinamide is present in many plants and animal products, and dietary supplements. It is water-soluble and can be consumed every day. It is used to treat certain types of skin diseases, cancer, and diabetes. Consuming niacinamide can help prevent B-3 deficiency. It's found in many foods like meat, fish, milk, eggs, green vegetables, fruits, and cereals. It is a chemo-sensitizing agent and a type of radio-sensitizing agent.
MARKET DRIVERS
The growing usage of niacinamide in cancer treatment is one of the major factors propelling the niacinamide market.
Niacinamide increases blood flow to cancer cells and blocks certain enzymes required for those cells to repair DNA damage. This makes cancer cells more responsive to chemotherapy and radiation treatment. A scientific study in 2015 shows that individuals with a high risk for skin cancers could prevent the disease with oral niacinamide intake. In addition, Niacinamide reduces the PARP-1 gene's excess activation, related to cell senescence, cancer, and aging, and protects against UV-induced immunosuppression. It is also used for treating chronic kidney disease. Loss of kidney function affects the body’s ability to clean and filter blood and control blood pressure. According to research, niacinamide may help lower phosphate levels in individuals with kidney dysfunction by preventing its absorption.
The rising demand for skin care products and growing usage of niacinamide in skin care is further anticipated to boost the niacinamide market growth.
Niacinamide reduces oil production, which helps treat acne. It also reduces fine lines and pigmentation and gives protection again sun rays and wrinkles. It is also used in maintaining cholesterol levels in the body. In addition, Niacinamide helps to reduce inflammation-related skin diseases like eczema, acne, and other skin conditions that cause redness. For instance, Mamaearth, an Indian-based skincare company, introduced its Niacin Face Toner with Niacinamide & Witch Hazel for Acne and Open Pores. Niacinamide is also used in growing long hair due to its circulation-boosting properties. It enhances the appearance and feel of hair, suppleness, and sheen. It also improves the texture of hair, helping to build Keratin.
Niacin (Vitamin B3) is also used for animal metabolism, increasing market demand in coming years. This vitamin plays a role in production processes as well as the synthesis of fatty and amino acids, which is essential for the achievement of milk. Therefore, niacin supplements have positive benefits on cattle growth. Furthermore, with its availability in feed and internal production, the microbial synthesis of niacin in the stomach is a vital source for dairy cows.
MARKET RESTRAINTS
On the other hand, a lack of awareness regarding the benefits of niacinamide and strict regulatory forms are anticipated to showcase a negative impact on the global niacinamide market. Side effects such as stomach upset, gas, dizziness, headache, and rash may challenge the market growth. In addition, Niacinamide cream may cause mild burning, itching, or redness.
REPORT COVERAGE
| REPORT METRIC | DETAILS |
| Market Size Available | 2025 to 2034 |
| Base Year | 2025 |
| Forecast Period | 2026 to 2034 |
| Segments Covered | By Grade,Form, End-User, and Region |
| Various Analyses Covered | Global, Regional & Country Level Analysis, Segment-Level Analysis; DROC, PESTLE Analysis, Porter's Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
| Regions Covered | North America, Europe, APAC, Latin America, Middle East & Africa |
| Market Leader Profiled | Merck KGaA, BASF SE, Lonza, Koninklijke DSM N.V., Bactolac Pharmaceuticals, Inc., Foodchem International Corporation, Evonik Industries AG, Jubilant Life Sciences Limited, Vertellus Specialties Inc. |
SEGMENTAL ANALYSIS
By Grade Insights
Based on the grade, the pharmaceutical-grade segment accounted for the highest share of the global niacinamide market in 2025. The increasing use of niacinamide in pharmaceuticals drives the segment forward. In addition, Niacinamide may be used as a pharmaceutical reference standard for the various chromatography techniques used to identify the analyte in plasma, pharmaceutical formulations, and infant/adult nutritional formula powder.
By Form Insights
Based on the form, the granular segment led the niacinamide market worldwide in 2025. Granular niacinamide is used in baking mixes, cereals, nutrition bars, nutrition powders, and hard-shell capsules, among other food, beverage, and dietary supplement applications. Using niacinamide in levels less than 35 mg per day is considered safe.
By End-User Insights
Based on the end-user, the human nutrition segment is anticipated to lead the niacinamide market worldwide during the forecast period. Vitamin B3 is necessary for our body's cells to carry out important chemical reactions and transform the food you eat into useful energy. Niacinamide, or vitamin B3, is commonly found in animal-based foods like meat and chicken, and nicotinic acid, or vitamin B3, in plant-based foods like nuts, seeds, and green leafy vegetables.
REGIONAL ANALYSIS
North America dominated the market for niacinamide worldwide in 2025, owing to the awareness of niacinamide and the increasing consumption of niacinamide-related foods. According to the National Institutes of Health, most people in the United States consume vitamin B3 daily without needing a supplement. In addition, the US FDA has approved niacin to treat high cholesterol and prevent vitamin B3 deficiency and related illnesses, including pellagra.
The Asia Pacific region is expected to have the largest share during the forecast period. Niacinamide has become quite popular recently. These products are used in India due to awareness of product usage among people for their skin and the reduction of other diseases. Other factors such as increasing demand for efficient cosmetics, growing healthcare expenditure., many pharmaceutical and cosmeceutical companies, and increasing research and development drive the region forward.
The Europe niacinamide market has moderate growth. Factors such as increasing incidences of dairy cattle, increasing research and development, increased milk production rising obesity, presence of key market players, and unhealthy food consumption are favoring the European market. In addition, many people in Europe do not follow a diet, which is accelerated by diseases such as diabetes and heart-related diseases, resulting in demand for the niacinamide market.
KEY MARKET PLAYERS
Some of the companies that are playing a dominating role in the global niacinamide market
- Merck KGaA
- BASF SE
- Lonza
- Koninklijke DSM N.V.
- Bactolac Pharmaceuticals, Inc.
- Foodchem International Corporation
- Evonik Industries AG
- Jubilant Life Sciences Limited
- Vertellus Specialties Inc.
- Vanetta
- Fagron, Inc.
- ZHEJIANG NHU COMPANY LTD.
- Brother Enterprises Holding Co., Ltd.
- Lasons India Pvt. Ltd.
RECENT MARKET DEVELOPMENTS
- Fision GlowPlex, in 2021, TRI-K combined the strength of peptides with gold standard niacinamide, using its renowned NaturePep natural peptide technology.
- ScieGen, a Bactolac Pharmaceutical subsidiary, will increase production in April 2020 to fulfill the expanding demands of the nutraceutical business.
- In July 2019, Jubilant Life Sciences will raise the price of Vitamin B3 by 10%.
MARKET SEGMENTATION
This research report has been segmented and sub-segmented into the following categories based on Grade, Form, End-user & Region.
By Grade
- Pharmaceutical Grade
- Feed Grade
By Form
- Granular
- Powder
- Liquid
By End-User
- Pharmaceuticals
- Cosmeceuticals
- Human Nutrition
- Animal Nutrition
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa